HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Piette Selected Research

Chloroquine (Aralen)

2/2001The potential place of chloroquine in the treatment of HIV-1-infected patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Piette Research Topics

Disease

8Neoplasms (Cancer)
04/2013 - 04/2000
4Inflammation (Inflammations)
12/2015 - 11/2000
4Photosensitivity Disorders (Photodermatitis)
07/2001 - 01/2000
3Carcinoma (Carcinomatosis)
05/2005 - 08/2000
3Colonic Neoplasms (Colon Cancer)
05/2005 - 08/2000
2Necrosis
07/2001 - 08/2000
2Infections
02/2001 - 10/2000
1Type 2 Diabetes Mellitus (MODY)
01/2014
1Obesity
01/2014
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2014
1Insulin Resistance
01/2014
1Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2013
1Pain (Aches)
07/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2008
1Carcinogenesis
03/2008
1Urinary Bladder Neoplasms (Bladder Cancer)
03/2008
1Hypersensitivity (Allergy)
04/2001
1HIV Infections (HIV Infection)
02/2001
1Acquired Immunodeficiency Syndrome (AIDS)
02/2001
1Horse Diseases (Horse Disease)
11/2000
1Airway Obstruction (Choking)
11/2000
1Leukemia
01/2000

Drug/Important Bio-Agent (IBA)

6NF-kappa B (NF-kB)IBA
07/2001 - 01/2000
5Proteins (Proteins, Gene)FDA Link
04/2013 - 01/2000
3CytokinesIBA
01/2014 - 08/2000
3Transcription Factors (Transcription Factor)IBA
10/2000 - 01/2000
2OligonucleotidesIBA
04/2013 - 03/2008
2Pharmaceutical PreparationsIBA
07/2008 - 02/2001
21-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2008 - 01/2000
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2008 - 07/2001
2Singlet OxygenIBA
07/2001 - 01/2000
1Type I Tumor Necrosis Factor ReceptorsIBA
12/2015
1InflammasomesIBA
01/2014
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2014
1RutheniumIBA
04/2013
1Anti-Bacterial Agents (Antibiotics)IBA
07/2008
1Antiviral Agents (Antivirals)IBA
07/2008
1AntioxidantsIBA
03/2008
1Photosensitizing Agents (Photosensitizers)IBA
03/2008
1p38 Mitogen-Activated Protein KinasesIBA
03/2008
1hypericinIBA
03/2008
1CeramidesIBA
05/2005
1ProteomeIBA
05/2005
1DNA (Deoxyribonucleic Acid)IBA
07/2001
1Cysteine (L-Cysteine)FDA Link
07/2001
1Cytochromes c (Cytochrome c)IBA
07/2001
1pyropheophorbide-a methylesterIBA
07/2001
1CaspasesIBA
07/2001
1mannose-6-phosphate rich phosphomannanIBA
07/2001
1Deuterium Oxide (Heavy Water)IBA
07/2001
1prolinedithiocarbamate (PDTC)IBA
07/2001
14,4'- (1,2- dimethyl- 1,2- ethanediyl)bis- 2,6- piperazinedioneIBA
04/2001
1IronIBA
02/2001
1Chloroquine (Aralen)FDA LinkGeneric
02/2001
1Complementary DNA (cDNA)IBA
10/2000
1Interleukin-6 (Interleukin 6)IBA
08/2000
1Messenger RNA (mRNA)IBA
08/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2000
1NF-KappaB Inhibitor alphaIBA
01/2000

Therapy/Procedure

3Therapeutics
04/2013 - 10/2000
2Photochemotherapy (Photodynamic Therapy)
03/2008 - 01/2000
1Drug Therapy (Chemotherapy)
10/2011